Pre-Clinical Compound Validation Program

• Immunohistochemical analysis of retinal tissues
  
  
• ELISA and mass spec measurement of therapeutic efficacy
  
  
• Screening and validation of genetic markers of AMD
  
  
• Angiogenesis assays
  
  
• Electroretinogram measure of visual function
  
  
• Inflammation models of AMD
  
  
• Visual acuity behavioral assessment